The Continuum of Prevention and Heart Failure in Cardiovascular Medicine: A Joint Scientific Statement from the Heart Failure Society of America and The American Society for Preventive Cardiology.
Aug 13, 2025DOI: 10.1016/j.cardfail.2025.06.013Journal ArticleJCF
Written by: Anuradha LalaCraig BeaversVanessa BlumerLaprincess BrewerDiana DE Oliveira-GomesSandra B DunbarHannah EveryRichard FerraroBonnie KyJames L JanuzziFrancoise MarvelRobert J MentzErin MichosJagat NarulaKhuram NasirPradeep NatarajanLori Ann PetersonFatima RodriguezMichael D ShapiroJenna SkowronskiRandall C StarlingPam TaubRyan J TedfordQuentin YoumansShelley ZierothMartha Gulati
Find these authors on Roon
RM
Dr. Robert Mentz
Advanced Heart Failure · Duke University
PN
Dr. Pradeep Natarajan
Preventive Cardiology · MGH
MS
Dr. Michael Shapiro
Preventive Cardiology · Wake Forest School of Medicine
JS
Dr. Jenna Skowronski
Advanced Heart Failure · UNC
RS
Dr. Randall Starling
Advanced Heart Failure · Cleveland Clinic
QY
Dr. Quentin Youmans
Advanced Heart Failure · Northwestern Medicine
MG
Dr. Martha Gulati
Preventive Cardiology · Houston Methodist
Summary
Heart disease is the leading cause of death worldwide, with heart failure (HF) recognized as its most severe and debilitating manifestation. Though remarkable advancements have led to the establishment of life-saving and quality-of-life-enhancing medical and device-based therapies for HF, HF-related mortality trends have increased over the past decade. To combat this worldwide epidemic, care must evolve so that preventive recommendations are not siloed from HF management. Prevention must be prioritized more broadly, not only in the early detection and deterrence of HF but across a patient's lifespan in conjunction with therapeutic intervention. Members of the Heart Failure Society of America and the American Society for Preventive Cardiology created this joint Societal Scientific Statement on the Prevention of Heart Failure to emphasize the links between cardiovascular disease prevention and HF and offer a conceptual roadmap along which to consider all aspects of preventive care. This includes primary prevention to reduce the burden of HF, secondary prevention to reduce the impact of HF among those with an established diagnosis of HF, and tertiary prevention, which encompasses the management of risk factors in patients who require advanced therapies, including durable mechanical circulatory support and heart transplantation.
JS
Dr. Jenna Skowronski
Cardiology · Advanced Heart Failure & TransplantationUniversity of North Carolina at Chapel HilljennasChapel Hill, NC, USA
